On October 22, 2021, the Centers for Medicare & Medicaid Services (CMS) announced it has issued guidance requiring states to cover COVID-19 treatment without cost sharing for people enrolled in Medicare, Medicaid and Children’s Health Insurance Program (CHIP), supported by the American Rescue Plan. This coverage includes treatments and therapies for post-COVID-19 conditions, referred to as “long COVID,” as well as conditions that may seriously complicate the treatment of COVID-19 if otherwise covered under the state plan, and specialized equipment and drugs authorized by the FDA to treat or prevent COVID-19. The guidance states that “CMS will apply the statutory interpretations in this guidance on a prospective basis beginning with the date of issuance of this letter.”
By using this site, you agree to our updated Privacy Policy.
Necessary Cookies
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
Analytical Cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.